2-[[5-[1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-3-yl]methylamino]-1,4,5,6-tetrahydropyrimidin-5-ol
C22H23FN4O2 — CID 18693332
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[5-[1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-3-yl]methylamino]-1,4,5,6-tetrahydropyrimidin-5-ol
2-[[5-[1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-3-yl]methylamino]-1,4,5,6-tetrahydropyrimidin-5-ol (PubChem CID 18693332) has the molecular formula C22H23FN4O2 and a molecular weight of 394.45 g/mol. Its IUPAC name is 2-[[5-[1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-3-yl]methylamino]-1,4,5,6-tetrahydropyrimidin-5-ol.
Molecular Properties
| Compound Name | 2-[[5-[1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-3-yl]methylamino]-1,4,5,6-tetrahydropyrimidin-5-ol |
|---|---|
| PubChem CID | 18693332 |
| Molecular Formula | C22H23FN4O2 |
| Molecular Weight | 394.45 g/mol |
| Exact Mass | 394.18 |
| IUPAC Name | 2-[[5-[1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-3-yl]methylamino]-1,4,5,6-tetrahydropyrimidin-5-ol |
| SMILES | CC(c1ccc(-c2ccccc2)c(F)c1)c1cc(CNC2=NCC(O)CN2)no1 |
| InChI | InChI=1S/C22H23FN4O2/c1-14(16-7-8-19(20(23)9-16)15-5-3-2-4-6-15)21-10-17(27-29-21)11-24-22-25-12-18(28)13-26-22/h2-10,14,18,28H,11-13H2,1H3,(H2,24,25,26) |
| InChIKey | RHPVGFUMEOBYRO-UHFFFAOYSA-N |
| XLogP | 3.04 |
| TPSA | 82.68 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 394.45 |
| LogP ≤ 5 | 3.04 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 18693332 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.